NCT06278558 Psychological Factors Influencing Cancer Post-traumatic Growth
| NCT ID | NCT06278558 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier de Valenciennes |
| Condition | Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 289 participants |
| Start Date | 2023-11-10 |
| Primary Completion | 2026-11-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 289 participants in total. It began in 2023-11-10 with a primary completion date of 2026-11-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The study focuses on post-traumatic growth (positive changes linked to appreciation of life, personal strengths, social relationships...) in the context of different types of cancer and with a longitudinal approach to the care pathway. The aim of the study is to better understand whether psychological variables (emotional competence, psychological flexibility, psychological distress) and patients' care satisfaction, assessed at the start of the cancer treatment pathway, can influence their post-traumatic growth at the end of the chemotherapy protocol and 6 months later.
Eligibility Criteria
Inclusion Criteria: * Patients over 18 years of age * Patients in the initial phase of curative treatment for a 1st solid cancer * At the start of neo-adjuvant or adjuvant chemotherapy (1st course or 2nd course) * At less than 6 months from the initial diagnosis * Patient having given written consent to participate in the study Exclusion Criteria: * Patients with a previous history of cancer * Patients with incurable cancer progression, recurrence or relapse * Metastatic, brain, hematological or skin cancer * Patients who have difficulty understanding written French * Patient psychologically or physically unable to answer questionnaires
Contact & Investigator
Anne-Sophie Baudry
PRINCIPAL INVESTIGATOR
CH de Valenciennes
Frequently Asked Questions
Who can join the NCT06278558 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06278558 currently recruiting?
Yes, NCT06278558 is actively recruiting participants. Contact the research team at baudry-as@ch-valenciennes.fr for enrollment information.
Where is the NCT06278558 trial being conducted?
This trial is being conducted at Valenciennes, France.
Who is sponsoring the NCT06278558 clinical trial?
NCT06278558 is sponsored by Centre Hospitalier de Valenciennes. The principal investigator is Anne-Sophie Baudry at CH de Valenciennes. The trial plans to enroll 289 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.